Tacrine granted marketing approval for Alzheimer's disease.
D000544:Alzheimer Disease / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D013619:Tacrine / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013619:Tacrine